UnknownNot Applicable

Fib to Alb Ratio in Type 2 Dkd

50 participantsStarted 2024-01

Plain-language summary

Aimed to investigate the association of fibrinogen to albumin ratio (FAR) with DKD type 2 and to prove its possible role as a novel biomarker to predict and prevent DKD progression.

Who can participate

Age range18 Years – 80 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Age above 18 yrs. * 50 Pts with type 2 DM that have DKD (presence of albuminuria in association with diabetic retinopathy) and 50 pts with type 2 DM but have no DKD. Exclusion Criteria: * Age below 18 yrs. * Pts with ESKD, manifested cardiac valvular disease, acute infection, history of hepatitis, pts with DKA and Cancer. * Pt who refused to contribute in this study

What they're measuring

The association of fibrinogen to albumin ratio (FAR) with DKD type 2.

Timeframe: baseline

Trial details

NCT IDNCT05691985

SponsorAssiut University

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2024-03

Contact for this trial

Abdallah Gamal Abd El Hafeez, Resident

01221248314 memo_star440@yahoo.com

View on ClinicalTrials.gov More CKD trials